BC-DXI-843

BC-DXI-843 is a potent and specific AIMP2-DX2 inhibitor with an IC 50 of 0.92 μM, more than 100-fold selectivity over AIMP2 (IC 50 >100 μM) in a luciferase assay. BC-DXI-843 acts as a promising lead targeting AIMP2-DX2 in lung cancer .

Specifications & Purity:

Grade: Moligand™

MDL Number: MFCD32693926

Molecular Formula: C28H26N4O4S2

Molecular Weight: 546.66

PubChem CID: 146673132

Isomeric SMILES: CC1=CC=C(C=C1)S(=O)(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)NC4=NC(=CS4)C5=CC=C(C=C5)OC

Storage Temperature: Protected from light;Store at -20°C;Argon charged

Shipped in: Ice chest + Ice pads

UPC:

41116133

Weight:

1.09 Ounces

HazmatClass:

Yes

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

B987751-100mg

Country of Origin:

China

CAS:

2421117-98-6

Product Size:

100mg

Harmonized Tariff Code:

2931.90.90